Vienna BioCenter

🔬 Did you know that every single one of the top 20 global pharma companies are represented in Vienna? 👩⚕️ That's right - if you ever thought Vienna was just about coffee, history, and classical music, it might be high time to reconsider - a city as diverse as its inhabitants, it has also become a thriving center for #lifesciences innovation. 💊 With 600 organisations and more than 41,000 professionals, Vienna is leading the charge in #biotech, #pharmaceuticals, and #healthcare advancement. But what truly sets the city apart is the perfect mix of talent, investment, and resources: almost 200,000 students across 26 universities make it a powerhouse for academic excellence, and with 4% of the local GDP dedicated to R&D (and 13.3 billion euros in annual sales), Vienna is proving that innovation and opportunity go hand in hand. Find out more about Vienna, a #CityofLifeSciences ➡️ https://lnkd.in/djz5iqgv #meetvienna #viennabusiness #businessinvienna 

2024 was a great year for IMBA! Stay tuned in the next weeks for this year’s highlights, starting with the biggest achievements by our Students and Postdocs in 2024. In 2024, 8 IMBA PhD students defended their doctoral theses. Congratulations Rut Gabarró Solanas, Clara Schmidt, Marie-Christin Röcklinger (Leitner), Esther Uijttewaal, PhD, Viktoria Holzmann, Joonsun Lee, Alison Deyett and Teresa Krammer, PhD! At this year’s Vienna BioCenter PhD Symposium, Alison Deyett received a PhD Award and Ralf Jansen Jensen received the Lauwers Award for best Monday seminar talk. 2024 was a year full of fellowships! Congratulations to all our PhDs and postdocs who received prestigious fellowships to support their research projects. Our PhD students received DOC fellowships from the Austrian Academy of Sciences and BIF fellowships from the Boehringer Ingelheim Fonds. Our postdocs were, amongst others, supported by the European Research Council (ERC) @Marie Sklodowska-Curie initiative, the Human Frontier Science Program (HFSP), the Engelhorn Foundation and the Austrian Academy of Sciences. Interested in doing a PhD or Postdoc at IMBA? Check out the career opportunities here: https://bit.ly/imbacareers

As the year wraps up, we’re celebrating the incredible successes and achievements of the Perutz community! 🎉 From poster prizes and first-author publications to prestigious fellowships and personal projects brought to life, 2024 has been an inspiring journey. Our monthly #SuccessStory campaign highlighted just a few of these milestones - take a look back with us in this short video, and let the good vibes inspire you for a successful year ahead! 🌟🎥 Universität Wien Medizinische Universität Wien

As we count down to the new year, we continue our recap of 2024’s highlights at the GMI! Today, we’ll look at the achievements of the GMI’s group leaders in the last year. Yan Ma and Nick Irwin started new research groups at the GMI this year, bringing their exciting research on gall formation and horizontal gene transfer to our institute. Frédéric Berger received an Emerging Fields Grant and a Standalone Grant from the Austrian Science Fund (FWF). Congratulations, Fred! Liam Dolan (Ó Dubhláin) was elected Full Member of the Austrian Academy of Sciences, a great honor for scientists in Austria! Want to know more about what happened at the GMI in 2024? Check out our news here: https://bit.ly/newsGMI

We are proud to share that HeartBeat.bio AG has been awarded a €587k HealthCare grant by the City of Vienna! This grant highlights the uniqueness and excellence of our human-centric drug discovery platform and reinforces our commitment to developing innovative treatments for patients suffering from heart failure. The funding will enable us to accelerate progress in tackling myocardial fibrosis and remodeling - a critical area of unmet medical need with limited treatment options currently available. We are incredibly grateful to the City of Vienna for their belief in our science, vision, and potential to make a difference for patients worldwide. https://lnkd.in/dTEC4bN8